Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
IFF vs SHW vs FMC vs CTVA vs HUN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Agricultural Inputs
Agricultural Inputs
Chemicals
IFF vs SHW vs FMC vs CTVA vs HUN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Agricultural Inputs | Agricultural Inputs | Chemicals |
| Market Cap | $20.70B | $78.14B | $1.68B | $54.47B | $2.60B |
| Revenue (TTM) | $10.79B | $23.94B | $3.43B | $17.89B | $5.69B |
| Net Income (TTM) | $839M | $2.60B | $-2.50B | $1.16B | $-324M |
| Gross Margin | 35.1% | 49.1% | 35.3% | 33.5% | 12.9% |
| Operating Margin | 8.0% | 16.1% | -59.5% | 13.8% | -1.0% |
| Forward P/E | 18.1x | 27.0x | 7.7x | 21.9x | — |
| Total Debt | $6.65B | $14.53B | $4.20B | $2.58B | $2.73B |
| Cash & Equiv. | $590M | $207M | $585M | $4.52B | $429M |
IFF vs SHW vs FMC vs CTVA vs HUN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| International Flavo… (IFF) | 100 | 60.9 | -39.1% |
| The Sherwin-William… (SHW) | 100 | 160.1 | +60.1% |
| FMC Corporation (FMC) | 100 | 13.6 | -86.4% |
| Corteva, Inc. (CTVA) | 100 | 297.1 | +197.1% |
| Huntsman Corporation (HUN) | 100 | 82.4 | -17.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IFF vs SHW vs FMC vs CTVA vs HUN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IFF lags the leaders in this set but could rank higher in a more targeted comparison.
SHW carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 246.5% 10Y total return vs CTVA's 193.8%
- 10.9% margin vs FMC's -72.9%
- 1.0% yield, 37-year raise streak, vs FMC's 17.4%
- 10.0% ROA vs FMC's -23.0%, ROIC 16.5% vs -21.2%
FMC is the clearest fit if your priority is income & stability.
- Dividend streak 7 yrs, beta 1.63, yield 17.4%
CTVA is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 2.9%, EPS growth 23.1%, 3Y rev CAGR -0.1%
- Lower volatility, beta 0.27, Low D/E 10.6%, current ratio 1.43x
- PEG 1.83 vs SHW's 3.90
- Beta 0.27, yield 0.9%, current ratio 1.43x
HUN ranks third and is worth considering specifically for momentum.
- +30.1% vs FMC's -59.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.9% revenue growth vs FMC's -18.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 10.9% margin vs FMC's -72.9% | |
| Stability / Safety | Beta 0.27 vs HUN's 1.82, lower leverage | |
| Dividends | 1.0% yield, 37-year raise streak, vs FMC's 17.4% | |
| Momentum (1Y) | +30.1% vs FMC's -59.8% | |
| Efficiency (ROA) | 10.0% ROA vs FMC's -23.0%, ROIC 16.5% vs -21.2% |
IFF vs SHW vs FMC vs CTVA vs HUN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IFF vs SHW vs FMC vs CTVA vs HUN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SHW leads in 2 of 6 categories
CTVA leads 1 • IFF leads 0 • FMC leads 0 • HUN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SHW leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SHW is the larger business by revenue, generating $23.9B annually — 7.0x FMC's $3.4B. SHW is the more profitable business, keeping 10.9% of every revenue dollar as net income compared to FMC's -72.9%. On growth, CTVA holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $10.8B | $23.9B | $3.4B | $17.9B | $5.7B |
| EBITDAEarnings before interest/tax | $1.7B | $4.5B | -$1.9B | $3.4B | $160M |
| Net IncomeAfter-tax profit | $839M | $2.6B | -$2.5B | $1.2B | -$324M |
| Free Cash FlowCash after capex | $400M | $2.9B | -$91M | $2.1B | $135M |
| Gross MarginGross profit ÷ Revenue | +35.1% | +49.1% | +35.3% | +33.5% | +12.9% |
| Operating MarginEBIT ÷ Revenue | +8.0% | +16.1% | -59.5% | +13.8% | -1.0% |
| Net MarginNet income ÷ Revenue | +7.8% | +10.9% | -72.9% | +6.5% | -5.7% |
| FCF MarginFCF ÷ Revenue | +3.7% | +12.1% | -2.7% | +11.5% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.6% | +6.8% | -4.1% | +11.0% | +0.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +116.6% | +7.5% | -17.8% | +12.6% | -3.3% |
Valuation Metrics
Evenly matched — IFF and FMC and CTVA each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 30.8x trailing earnings, SHW trades at a 39% valuation discount to CTVA's 50.7x P/E. Adjusting for growth (PEG ratio), CTVA offers better value at 4.24x vs SHW's 4.46x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $20.7B | $78.1B | $1.7B | $54.5B | $2.6B |
| Enterprise ValueMkt cap + debt − cash | $26.8B | $92.5B | $5.3B | $52.5B | $4.9B |
| Trailing P/EPrice ÷ TTM EPS | -55.51x | 30.85x | -0.75x | 50.71x | -9.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.13x | 26.99x | 7.68x | 21.90x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 4.46x | — | 4.24x | — |
| EV / EBITDAEnterprise value multiple | 13.64x | 21.05x | — | 13.74x | 19.79x |
| Price / SalesMarket cap ÷ Revenue | 1.90x | 3.31x | 0.48x | 3.13x | 0.46x |
| Price / BookPrice ÷ Book value/share | 1.46x | 17.14x | 0.80x | 2.24x | 0.87x |
| Price / FCFMarket cap ÷ FCF | 80.87x | 29.44x | — | 19.35x | 22.44x |
Profitability & Efficiency
SHW leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SHW delivers a 58.2% return on equity — every $100 of shareholder capital generates $58 in annual profit, vs $-82 for FMC. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to SHW's 3.16x. On the Piotroski fundamental quality scale (0–9), SHW scores 6/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.9% | +58.2% | -82.3% | +4.6% | -8.1% |
| ROA (TTM)Return on assets | +3.3% | +10.0% | -23.0% | +2.7% | -4.6% |
| ROICReturn on invested capital | +3.5% | +16.5% | -21.2% | +8.5% | -0.6% |
| ROCEReturn on capital employed | +4.4% | +21.3% | -25.9% | +8.6% | -0.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 2 | 6 | 2 |
| Debt / EquityFinancial leverage | 0.47x | 3.16x | 2.00x | 0.11x | 0.92x |
| Net DebtTotal debt minus cash | $6.1B | $14.3B | $3.6B | -$1.9B | $2.3B |
| Cash & Equiv.Liquid assets | $590M | $207M | $585M | $4.5B | $429M |
| Total DebtShort + long-term debt | $6.7B | $14.5B | $4.2B | $2.6B | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | 5.26x | 7.83x | -0.24x | 5.82x | -1.08x |
Total Returns (Dividends Reinvested)
CTVA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTVA five years ago would be worth $17,936 today (with dividends reinvested), compared to $1,994 for FMC. Over the past 12 months, HUN leads with a +30.1% total return vs FMC's -59.8%. The 3-year compound annual growth rate (CAGR) favors CTVA at 13.0% vs FMC's -44.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +19.7% | -3.1% | -6.0% | +20.0% | +47.7% |
| 1-Year ReturnPast 12 months | +11.6% | -9.5% | -59.8% | +22.4% | +30.1% |
| 3-Year ReturnCumulative with dividends | -10.4% | +40.9% | -82.7% | +44.4% | -32.5% |
| 5-Year ReturnCumulative with dividends | -34.5% | +14.4% | -80.1% | +79.4% | -38.0% |
| 10-Year ReturnCumulative with dividends | -10.3% | +246.5% | -27.4% | +193.8% | +59.2% |
| CAGR (3Y)Annualised 3-year return | -3.6% | +12.1% | -44.3% | +13.0% | -12.3% |
Risk & Volatility
Evenly matched — IFF and CTVA each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTVA is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than HUN's 1.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IFF currently trades 96.3% from its 52-week high vs FMC's 29.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.86x | 0.80x | 1.63x | 0.27x | 1.82x |
| 52-Week HighHighest price in past year | $84.19 | $379.65 | $44.78 | $85.63 | $15.89 |
| 52-Week LowLowest price in past year | $59.14 | $301.58 | $12.17 | $60.54 | $7.30 |
| % of 52W HighCurrent price vs 52-week peak | +96.3% | +83.5% | +29.9% | +94.7% | +94.1% |
| RSI (14)Momentum oscillator 0–100 | 60.5 | 45.3 | 36.7 | 43.3 | 60.6 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 1.6M | 3.2M | 3.4M | 6.2M |
Analyst Outlook
Evenly matched — SHW and FMC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IFF as "Buy", SHW as "Buy", FMC as "Hold", CTVA as "Buy", HUN as "Hold". Consensus price targets imply 22.9% upside for SHW (target: $389) vs -18.1% for HUN (target: $12). For income investors, FMC offers the higher dividend yield at 17.36% vs CTVA's 0.87%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $88.13 | $389.43 | $15.58 | $88.17 | $12.25 |
| # AnalystsCovering analysts | 33 | 38 | 42 | 37 | 33 |
| Dividend YieldAnnual dividend ÷ price | +2.0% | +1.0% | +17.4% | +0.9% | +5.7% |
| Dividend StreakConsecutive years of raises | 0 | 37 | 7 | 5 | 0 |
| Dividend / ShareAnnual DPS | $1.60 | $3.17 | $2.33 | $0.71 | $0.85 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +0.1% | +2.0% | +0.1% |
SHW leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CTVA leads in 1 (Total Returns). 3 tied.
IFF vs SHW vs FMC vs CTVA vs HUN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IFF or SHW or FMC or CTVA or HUN a better buy right now?
For growth investors, Corteva, Inc.
(CTVA) is the stronger pick with 2. 9% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). The Sherwin-Williams Company (SHW) offers the better valuation at 30. 8x trailing P/E (27. 0x forward), making it the more compelling value choice. Analysts rate International Flavors & Fragrances Inc. (IFF) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IFF or SHW or FMC or CTVA or HUN?
On trailing P/E, The Sherwin-Williams Company (SHW) is the cheapest at 30.
8x versus Corteva, Inc. at 50. 7x. On forward P/E, FMC Corporation is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Corteva, Inc. wins at 1. 83x versus The Sherwin-Williams Company's 3. 90x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — IFF or SHW or FMC or CTVA or HUN?
Over the past 5 years, Corteva, Inc.
(CTVA) delivered a total return of +79. 4%, compared to -80. 1% for FMC Corporation (FMC). Over 10 years, the gap is even starker: SHW returned +246. 5% versus FMC's -27. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IFF or SHW or FMC or CTVA or HUN?
By beta (market sensitivity over 5 years), Corteva, Inc.
(CTVA) is the lower-risk stock at 0. 27β versus Huntsman Corporation's 1. 82β — meaning HUN is approximately 586% more volatile than CTVA relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 3% for The Sherwin-Williams Company — giving it more financial flexibility in a downturn.
05Which is growing faster — IFF or SHW or FMC or CTVA or HUN?
By revenue growth (latest reported year), Corteva, Inc.
(CTVA) is pulling ahead at 2. 9% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, SHW leads at 2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IFF or SHW or FMC or CTVA or HUN?
The Sherwin-Williams Company (SHW) is the more profitable company, earning 10.
9% net margin versus -64. 6% for FMC Corporation — meaning it keeps 10. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SHW leads at 16. 1% versus -54. 4% for FMC. At the gross margin level — before operating expenses — SHW leads at 48. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IFF or SHW or FMC or CTVA or HUN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Corteva, Inc. (CTVA) is the more undervalued stock at a PEG of 1. 83x versus The Sherwin-Williams Company's 3. 90x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, FMC Corporation (FMC) trades at 7. 7x forward P/E versus 27. 0x for The Sherwin-Williams Company — 19. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SHW: 22. 9% to $389. 43.
08Which pays a better dividend — IFF or SHW or FMC or CTVA or HUN?
All stocks in this comparison pay dividends.
FMC Corporation (FMC) offers the highest yield at 17. 4%, versus 0. 9% for Corteva, Inc. (CTVA).
09Is IFF or SHW or FMC or CTVA or HUN better for a retirement portfolio?
For long-horizon retirement investors, Corteva, Inc.
(CTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 27), 0. 9% yield, +193. 8% 10Y return). Huntsman Corporation (HUN) carries a higher beta of 1. 82 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CTVA: +193. 8%, HUN: +59. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IFF and SHW and FMC and CTVA and HUN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IFF is a mid-cap quality compounder stock; SHW is a mid-cap quality compounder stock; FMC is a small-cap income-oriented stock; CTVA is a mid-cap quality compounder stock; HUN is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.